Xylos Corporation To Report On Significant Biocellulose Technology Advances At The In3 East Conference
LANGHORNE, Pa.--(BUSINESS WIRE)--Xylos Corporation (“Xylos” or the “Company”) is presenting a technology and business update on its developments in unique biocellulose-based medical devices and combination drug / device “convergence” technology at the Investment In Innovation (In3) Medical Device Summit in Boston, MA (October 18-20, 2006).